EcoDrugPlus

Adrenoceptor Alpha 1bb

Ensembl ID : ENSAPEG00000018004
Gene Symbol: ADRA1BB
1 Cross references
192 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSAPEG00000017644
Gene Symbol: ADRA1D
1 Cross references
195 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSAPEG00000007744
Gene Symbol: ADRA2A
1 Cross references
160 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSAPEG00000005670
Gene Symbol: ADRA2A
1 Cross references
176 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSAPEG00000018326
Gene Symbol: ADRA2B
1 Cross references
175 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSAPEG00000021739
Gene Symbol: ADRA2B
1 Cross references
156 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSAPEG00000016898
Gene Symbol: ADRA2C
1 Cross references
162 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSAPEG00000014278
Gene Symbol: ADRA2C
2 Cross references
156 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSAPEG00000017001
Gene Symbol: ADRB1
1 Cross references
163 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSAPEG00000015923
Gene Symbol: ADRB2
1 Cross references
168 Possible Orthologues:

Adrenoceptor Beta 2, Surface A

Ensembl ID : ENSAPEG00000011560
Gene Symbol: ADRB2A
1 Cross references
196 Possible Orthologues:

Adrenoceptor Beta 3a

Ensembl ID : ENSAPEG00000014371
Gene Symbol: ADRB3A
1 Cross references
197 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).